Download
Company intelligence · Prepared from public filings
Prosapient Limited
ACTIVENo. 10704431Incorporated 3 Apr 2017Londonexpert research platform
Register data as of 27 Aug 2026
71 filings read · view all sources ↓
Watch this company71 filings read · view all sources ↓
Raised, filed rounds
£15.9m
Priced rounds
11
Peak step-up
6.0x
Peak implied valuation
£68.2m
Last allotment
Oct 2023
Exhibit 1
Implied valuation at each priced allotment, 2017 to 2023
Implied post-money, GBP · price per share beneath each point · from SH01 filings
Source: Companies House, forms SH01 filed by Prosapient Limited; Tero analysis. Each point is one filed allotment; click any point to open the underlying filing.
Exhibit 2
Funding rounds, as filed
| Allotted | Share class | Price / share | Raised | Implied post-money | Step vs prior | Source |
|---|---|---|---|---|---|---|
| 16 Oct 2023 | PREFERENCE and SERIES A1 | £18.92 | £1.5m | £46.0m | ▼ 0.63x | SH01 ↗ |
| 12 Feb 2021 | Series A2, Series A1 | £30.00 | £3.7m | £68.2m | ▲ 1.5x | SH01 ↗ |
| 11 Dec 2020 | SERIES A1 and SERIES A2 | £20.26 | £5.1m | £42.7m | · 1.0x | SH01 ↗ |
| 10 Feb 2020 | Ordinary and A Ordinary | £20.26 | £3.9m | £37.4m | ▲ 3.0x | SH01 ↗ |
| 30 Nov 2018 | Ordinary | £6.79 | £500k | £10.6m | ▲ 1.4x | SH01 ↗ |
| 15 Jul 2018 | Ordinary | £4.98 | £1.0m | £7.4m | ▲ 4.0x | SH01 ↗ |
| 23 Feb 2018 | Ordinary | £1.25 | £60k | £1.6m | · 1.0x | SH01 ↗ |
| 23 Feb 2018 | Ordinary | £1.24 | £44k | £1.6m | · 1.0x | SH01 ↗ |
| 8 Nov 2017 | Ordinary | £1.24 | £60k | £1.5m | · 1.0x | SH01 ↗ |
| 8 Nov 2017 | Ordinary | £1.25 | £40k | £1.5m | · 1.0x | SH01 ↗ |
| 8 Nov 2017 | Ordinary | £1.25 | £50k | £1.5m | first | SH01 ↗ |
| Total, 11 priced rounds | £15.9m | |||||
Source: Companies House filing history, company 10704431. Every row links to the filed document it was read from. Prices and share counts as filed; implied post-money is price per share times shares in issue after the allotment.
Methodology
Notes. Raised is the sum of shares allotted times price per share across priced allotments filed on form SH01. Peak step-up is the highest price per share divided by the first priced round. Implied post-money is price per share times shares in issue after the allotment: an approximation that ignores class rights and unexercised options. Allotments classified as option-scheme or nominal issues are excluded from the trajectory.Primary documents
Every figure on this page is read from a document filed at Companies House and links to it. The full record is public: filing history of Prosapient Limited at Companies House ↗. Tero retains an archived copy of each parsed filing. Information, not investment advice.